A Metallurgical Dynamics-Based Method for Production State Characterization and End-Point Time Prediction of Basic Oxygen Furnace Steelmaking

Abstract

Basic Oxygen Furnace (BOF) steelmaking is an important way for steel production. Correctly recognizing different blowing periods and abnormal refining states is significant to ensure normal production process, while accurately predicting the end-point time helps to increase the first-time qualification rate of molten steel. Since the decarburization products CO and CO2 are the main compositions of off-gas, information of off-gas is explored for BOF steelmaking control. However, the problem is that most of the existing research directly gave the proportions of CO and CO2 as model input but barely considered the variation information of off-gas to describe the production state. At the same time, the off-gas information can be expected to recognize the last blowing period and predict the end-point time earlier than the existing methods that are based on sub-lance or furnace flame image, but little literature makes an attempt. Therefore, this work proposes a new method based on functional data analysis (FDA) and phase plane (PP), defined as FDA-PP, to describe and predict the BOF steelmaking process from the metallurgical dynamics viewpoint. This method extracts the total proportion of CO and CO2 and its first-order derivative as dynamics features of steelmaking process via FDA, which indicate the reaction velocity and acceleration of decarburization reaction, and describes the evolution of dynamics features via PP. Then, the FDA-PP method extracts the features of phase trajectories for production state recognition and end-point time prediction. Experiments on a real production dataset demonstrate that the FDA-PP method has higher production state recognition accuracy than the classical phase space, SVM, and BP methods, which is 87.78% for blowing periods of normal batches, 90.94% for splashing anomaly, and 81.29% for drying anomaly, respectively. At the same time, the FDA-PP method decreases the mean relative prediction error (MRE) of the end-point time prediction for abnormal batches by about 10% compared with the SVM and BP methods.